Home » Topics » Regulatory » Patents

Patents
RSS

Arete Therapeutics describes sEH inhibitors for the treatment of hypertension

Aug. 18, 2009

Panacos synthesizes new series of anti-HIV agents

Aug. 17, 2009

Endacea describes adenosine A1 antagonists as diagnostic agents

Aug. 17, 2009

Merck Sharpe & Dohme and Merck & Co. report PARP inhibitors for cancer treatment

Aug. 17, 2009

Novel gamma-secretase modulators in early development at EnVivo Pharmaceuticals

Aug. 17, 2009

Allergan claims sphingosine 1-phosphate receptor ligands as analgesics

Aug. 17, 2009

Novel tyrosine hydroxylase inducers discovered by French investigators

Aug. 14, 2009

Novel alpha2-adrenoceptor ligands in early development at Allergan

Aug. 14, 2009

Merck & Co. describe c-Met kinase inhibitors for cancer treatment

Aug. 14, 2009

LG Life Sciences claims glucokinase activators for the treatment of diabetes

Aug. 14, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...